Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Angiogenesis.

Adair TH, Montani JP.

San Rafael (CA): Morgan & Claypool Life Sciences; 2010.

2.
3.

Skeletal muscle angiogenesis. A possible role for hypoxia.

Wagner PD.

Adv Exp Med Biol. 2001;502:21-38. Review.

PMID:
11950140
4.

Molecular basis of angiogenesis and cancer.

Tonini T, Rossi F, Claudio PP.

Oncogene. 2003 Sep 29;22(42):6549-56. Review.

PMID:
14528279
5.

Broad targeting of angiogenesis for cancer prevention and therapy.

Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD.

Semin Cancer Biol. 2015 Dec;35 Suppl:S224-S243. doi: 10.1016/j.semcancer.2015.01.001. Epub 2015 Jan 16. Review.

6.

Microbubbles-echistatin.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2005 Feb 18 [updated 2012 Jan 11].

7.

Incorporation of Antiangiogenic Therapy Into the Non-Small-Cell Lung Cancer Paradigm.

Chu BF, Otterson GA.

Clin Lung Cancer. 2016 Nov;17(6):493-506. doi: 10.1016/j.cllc.2016.05.020. Epub 2016 Jun 8. Review.

PMID:
27381269
8.

99mTc-Ethylenedicysteine-endostatin.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2005 Mar 3 [updated 2011 Dec 14].

9.

Advances and challenges in skeletal muscle angiogenesis.

Olfert IM, Baum O, Hellsten Y, Egginton S.

Am J Physiol Heart Circ Physiol. 2016 Feb 1;310(3):H326-36. doi: 10.1152/ajpheart.00635.2015. Epub 2015 Nov 25. Review.

10.

Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.

Battegay EJ.

J Mol Med (Berl). 1995 Jul;73(7):333-46. Review.

PMID:
8520966
11.

Issues and challenges for antiangiogenic therapies.

Miller KD.

Breast Cancer Res Treat. 2002 Oct;75 Suppl 1:S45-50; discussion S57-8. Review.

PMID:
12353823
12.

Normalization of the vasculature for treatment of cancer and other diseases.

Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK.

Physiol Rev. 2011 Jul;91(3):1071-121. doi: 10.1152/physrev.00038.2010. Review. Erratum in: Physiol Rev. 2014 Apr;94(2):707.

13.

Importance of anti-angiogenic factors in the regulation of skeletal muscle angiogenesis.

Olfert IM, Birot O.

Microcirculation. 2011 May;18(4):316-30. doi: 10.1111/j.1549-8719.2011.00092.x. Review.

PMID:
21418382
14.

Antiangiogenesis drug design: multiple pathways targeting tumor vasculature.

Zhong H, Bowen JP.

Curr Med Chem. 2006;13(8):849-62. Review.

PMID:
16611071
15.

Overview of angiogenesis: Biologic implications for antiangiogenic therapy.

Ellis LM, Liu W, Ahmad SA, Fan F, Jung YD, Shaheen RM, Reinmuth N.

Semin Oncol. 2001 Oct;28(5 Suppl 16):94-104. Review.

PMID:
11706401
16.

Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.

Zhao Y, Adjei AA.

Oncologist. 2015 Jun;20(6):660-73. doi: 10.1634/theoncologist.2014-0465. Epub 2015 May 22. Review.

17.

Angiogenesis in endocrine tumors.

Turner HE, Harris AL, Melmed S, Wass JA.

Endocr Rev. 2003 Oct;24(5):600-32. Review.

PMID:
14570746
18.

[Angiogenesis and antiangiogenic cancer therapy].

Pour L, Hájek R, Buchler T, Maisnar V, Smolej L.

Vnitr Lek. 2004 Dec;50(12):930-8. Review. Czech.

PMID:
15717808
19.

Angiogenesis and scar formation in healing wounds.

DiPietro LA.

Curr Opin Rheumatol. 2013 Jan;25(1):87-91. doi: 10.1097/BOR.0b013e32835b13b6. Review.

PMID:
23114588
20.

[Antiangiogenic treatment of cancer].

Mauriz JL, Linares P, González P, Culebras JM.

Cir Esp. 2005 Jul;78(1):3-11. Review. Spanish.

Supplemental Content

Support Center